Generating Genome-Scale Candidate Gene Lists for Pharmacogenomics

Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis

(2008) Esther Byun et al.   ARCHIVES OF NEUROLOGY

Prediction of drug-target interaction networks from the integration of chemical and genomic spaces

(2008) Y. Yamanishi et al.   BIOINFORMATICS

CYP4F2 genetic variant alters required warfarin dose

(2008) M. D. Caldwell et al.   BLOOD

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

(2008) G. M. Cooper et al.   BLOOD

Gemcitabine and Cytosine Arabinoside Cytotoxicity: Association with Lymphoblastoid Cell Expression

(2008) L. Li et al.   CANCER RESEARCH

Warfarin Pharmacogenomics: A big step forward for individualized medicine: enlightened dosing of warfarin

(2008) Darlene J Elias et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine

(2008) Hamdi Jarjanazi et al.   HUMAN MUTATION

Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans

(2008) R. S. Huang et al.   MOLECULAR CANCER THERAPEUTICS

A navigator for human genome epidemiology

(2008) Wei Yu et al.   NATURE GENETICS

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

(2008) Mark I. McCarthy et al.   NATURE REVIEWS GENETICS

Pharmacogenomics — Ready for Prime Time?

(2008) Susan B. Shurin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regulating Off-Label Drug Use — Rethinking the Role of the FDA

(2008) Randall S. Stafford   NEW ENGLAND JOURNAL OF MEDICINE